Rationale and design of the RESOLVE trial: lanreotide as a...

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease

Gevers, Tom JG, Chrispijn, Melissa, Wetzels, Jack FM, Drenth, Joost PH
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
BMC Nephrology
DOI:
10.1186/1471-2369-13-17
Date:
December, 2012
File:
PDF, 164 KB
english, 2012
Conversion to is in progress
Conversion to is failed